InSight, a privately-held company, has been one of the pioneers in the field of biosimilars.
Since 1995, InSight is a leading developer of high-quality biosimilar therapeutics.

Our technological expertise and infrastructure enable full-cycle product development, commercial manufacturing and product commercialization.

Our mission: 

Improving patient benefit by expanding access to biologic drugs